The significance of the result lies in what it replaces. Conventional COF synthesis typically demands days of heating under aggressive acid- or base-catalysed conditions, extensive screening of solvents and temperatures, and careful matching of reaction conditions to each monomer combination. Even then, many products emerge with imperfect crystallinity or compromised porosity, the two properties that make COFs valuable for gas separation, catalysis, energy storage and proton conduction. The new strategy, by contrast, produces imide-, imine-, hydrazone- and sp2-carbon-linked COFs within hours, with high crystallinity and porosity, using a catalyst that can be recovered and used again.

Benzimidazole occupies a special position among organic molecules because it is amphiprotic: it can donate a hydrogen bond through its N-H group and accept one through its pyridine-like nitrogen. That dual character is the engine of the new method. Unlike conventional acid or base catalysis, which activates monomers by proton transfer, the benzimidazole catalysts engage monomers, intermediates and transition states simultaneously through explicit hydrogen-bonding interactions, lowering the energy barrier at every step of the polymerization rather than at just one.

The authors demonstrate the approach most thoroughly on imide-linked COFs, a class prized for its chemical robustness and its applications in batteries, sensing and carbon capture. In the prototypical TAPB-PMDA-COF, formed from a triamine and a dianhydride, the catalyst accelerates the imidization reaction while promoting its reversibility, so that the growing network can continuously repair defects and settle into the thermodynamically favoured crystalline state. Powder X-ray diffraction profiles of the resulting materials show sharp reflections and narrow full widths at half maximum, hallmarks of long-range order that typically require days of solvothermal treatment to achieve.

Control is a second virtue of the method. Because the catalyst acts through noncovalent interactions rather than stoichiometric consumption, the reaction outcome can be tuned simply by varying the catalyst-to-monomer ratio. This knob allows the team to balance reaction rate against error correction: too little catalyst leaves the system slow and kinetically trapped, while the right proportion drives rapid bond formation and rapid bond exchange in parallel, the combination that crystalline polymer growth requires. The same logic extends across linkage chemistries, as the team showed by preparing the imine-linked TPB-DMTP-COF, the hydrazone-linked COF-43 and the sp2-carbon-conjugated sp2c-COF-16 under the same catalytic regime.

Theoretical calculations by Hongde Yu and Thomas Heine at the Technical University of Dresden, performed with density functional theory, support this mechanistic picture. The computations indicate that hydrogen-bonding interactions with the catalyst stabilize the transition states of the linkage-forming reactions and lower activation barriers for both the forward and reverse directions. Reversibility is the crucial ingredient: a network that can break and remake its bonds while it forms is one that can anneal itself into crystallinity, whereas an irreversible polymerization locks in disorder.

Scalability has long been the Achilles heel of COF chemistry, because many celebrated syntheses yield only tens or hundreds of milligrams after days of reaction. The hydrogen-bonding protocol supports a 1,000-fold scale-up, and the catalyst itself can be reused, addressing both the cost and the waste streams that would otherwise accompany industrial production. The scaled materials retain the high crystallinity and porosity of their small-batch counterparts, suggesting that the catalytic mechanism is robust to the heat- and mass-transfer realities of larger reactors.

The practical payoff is illustrated by proton conduction, a property central to fuel cells and electrolyzers. COFs prepared by the new route achieve benchmark proton conductivity, consistent with the team’s earlier work showing that crystalline porous frameworks can serve as exceptional proton-conducting electrolytes when their pores are engineered with appropriate carrier chemistry. Because the hydrogen-bonding synthesis delivers frameworks with well-defined channels and high surface areas, the resulting membranes combine the structural order needed for efficient transport with the mechanical and chemical stability demanded by devices.

The strategy also draws on a distinguished lineage in organic chemistry. Explicit hydrogen-bonding organocatalysis, pioneered for enantioselective reactions by chemists such as Peter Schreiner and Eric Jacobsen, relies on small-molecule donors that activate substrates without transferring protons. Applying that philosophy to polymer crystallization is conceptually elegant: the same interactions that guide a single reaction’s transition state can, when applied throughout a growing network, guide the entire system toward order. The result is a synthesis that is simultaneously faster, milder and more general than the harsh protocols it replaces.

For a field whose promise has often outrun its practicality, the message is striking. A cheap, recyclable heterocycle, acting through nothing more exotic than hydrogen bonds, can now build some of the most sophisticated materials in chemistry in hours instead of days, at gram scale instead of milligram scale, and with the crystalline quality that applications demand. If the approach proves as general across monomer families as the initial results suggest, hydrogen-bonding catalysis may become the default route to covalent organic frameworks, and the porous architectures built from it may finally move from the pages of review articles into the membranes, electrodes and catalysts of working technology.

Subject of Research: Hydrogen-bonding organocatalysis for the rapid, scalable synthesis of crystalline covalent organic frameworks

Article Title: Synthesis of covalent organic frameworks through hydrogen-bonding catalysis

Article References: Ye, X., Tao, S., Yu, H., Heine, T., Shao, H., Mu, X., Liu, Y., Xu, H., Lin, M., & Jiang, D. (2026). Synthesis of covalent organic frameworks through hydrogen-bonding catalysis. Nature Synthesis. https://doi.org/10.1038/s44160-026-01180-8

Image Credits: AI Generated

DOI: 10.1038/s44160-026-01180-8

Keywords: covalent organic frameworks, hydrogen-bonding catalysis, benzimidazole, organocatalysis, porous materials, imide-linked COFs, crystallinity, proton conduction, polymer synthesis, Nature Synthesis, scale-up, reversible polymerization

The challenge comes down to a distinction that sounds minor but matters enormously. In the syn form of a β-amino alcohol, the amino and hydroxyl groups sit on the same side of the carbon chain; in the anti form, they point to opposite sides. Both forms are chemically valid, but enzymes and drug targets can distinguish between them with ruthless precision, so a synthesis that delivers an uncontrolled mixture of the two is of limited use. The workhorse transformation for building these frameworks is the Henry reaction, a well-studied carbon–carbon bond-forming process that couples an aldehyde with a nitroalkane to produce a β-nitro alcohol. Because the nitro group can later be reduced to an amino group using well-established chemistry, the Henry reaction is a natural gateway to β-amino alcohols. The problem is that most catalytic versions of the reaction favor the syn product, leaving the anti form frustratingly out of reach.

That long-standing gap is now the target of a new study from Chiba University in Japan. A research team led by Professor Takayoshi Arai of the Graduate School of Science, working with co-authors Dr. Soushi Tsurusaki and Dr. Hidesato Iwama, has designed a chiral nickel catalyst that steers the Henry reaction decisively toward the anti product. The study, published online in the journal Angewandte Chemie International Edition on September 24, 2026, describes a catalyst architecture that does something conceptually elegant: it recruits several different types of molecular interactions at once, marshaling them in a single coordinated system to control how two reacting molecules find each other.

The catalyst, designated o-X-F4-PyBidine-Ni(OTf)2, where X is either bromine or iodine, is built around a nickel complex containing a molecular scaffold called PyBidine. The key innovation lies in a deliberate chemical modification: the researchers installed a bromine or iodine atom at a specific position on the ligand, creating a site capable of forming a halogen bond. Halogen bonding is a non-covalent interaction that arises when a region of positive electrostatic potential, known as a σ-hole, forms on the outer surface of a halogen atom. That positively charged patch can attract electron-rich functional groups on a nearby molecule, effectively gripping the aldehyde substrate and locking it into a defined orientation before the reaction takes place.

But halogen bonding is only one player in what is essentially a molecular choreography. Alongside the halogen bond, conventional hydrogen bonding, the familiar attractive force between a hydrogen atom and an electronegative atom, helps hold the aldehyde in place and simultaneously activates it toward reaction. Meanwhile, the nickel center, working in concert with a base called triethylamine, activates the nitroalkane, priming it to form the new carbon–carbon bond. The result of this multi-pronged arrangement is that the two reacting partners are held in a stretched-out, precisely aligned geometry that channels the reaction toward the anti product rather than the syn product that conventional catalysts tend to deliver.

The performance numbers are striking. Using alcohol as the solvent, the catalyst achieved up to 96:4 selectivity for the anti form over the syn form across many combinations of reactants, meaning that for every hundred product molecules, as many as ninety-six carried the desired anti geometry. Equally impressive is the enantioselectivity: the reaction delivered up to 99 percent enantiomeric excess, which means nearly every product molecule was the same one of the two possible mirror-image versions of the anti form. For a field where controlling both relative and absolute stereochemistry simultaneously is the central difficulty, those figures represent the kind of result that can change how chemists approach an entire class of targets.

The substrate scope adds to the practical appeal. The method proved compatible with a wide range of aromatic aldehydes, including examples bearing heterocyclic rings, which are common features in pharmaceutical compounds and often complicate catalytic reactions. Several kinds of nitroalkanes also worked as coupling partners. That breadth matters because a synthetic method that only functions with a narrow set of substrates rarely escapes the laboratory; one that tolerates diverse aromatic and heteroaromatic aldehydes has a realistic path toward applications in medicinal chemistry, where β-amino alcohol motifs recur constantly. As Professor Arai put it, the coordinated functioning of diverse interactions on a single catalyst represents an advance in state-of-the-art catalytic chemistry.

Curious about why the system works so well, the team turned to computer simulations to dissect the mechanism at a finer level of detail. These calculations revealed that the most favorable reaction pathway involves a halogen bond between the catalyst’s bromine atom and the aromatic ring of the aldehyde, working in tandem with hydrogen bonding and interactions between the nickel center and the nitro group of the nitroalkane. In other words, the selectivity is not the product of any single interaction but of several weak forces acting simultaneously, each contributing to the precise positioning of the reacting molecules. Interestingly, the bromine version of the catalyst was often more active than the iodine variant, possibly because bromine’s smaller size leaves more room for the substrate molecules to approach the reactive site.

Beyond the immediate synthetic payoff, the study carries a broader conceptual message for chemists who design catalysts. Halogen bonding, though increasingly recognized in recent years, has rarely been deployed alongside hydrogen bonding and metal coordination within a single catalytic system, particularly in protic solvents like alcohols, where such delicate interactions are easily disrupted. Demonstrating that these forces can cooperate on a metal catalyst under practical conditions opens a design space that catalyst developers have barely explored. Professor Arai noted that the higher-ordered cooperation of halogen bonds and hydrogen bonds on a metal catalyst in protic solvents is fascinating for the development of artificial metalloenzymes and halogen-bond-driven medicines, pointing toward catalytic systems that mimic the sophisticated multi-interaction control that enzymes achieve naturally.

The longer-term implications extend in several directions at once. For synthetic chemists, the work provides a dependable route to anti-β-amino alcohols, since the nitro group in the products can be readily converted into an amino group by well-established reduction chemistry, completing the gateway from the Henry reaction to the desired building blocks. For catalyst designers, it offers a template for engineering selectivity not through brute-force steric bulk but through the cooperative action of multiple weak, directional interactions. And for the emerging field of artificial metalloenzymes, synthetic catalysts that aspire to enzyme-like precision, it demonstrates that nature’s strategy of combining many subtle molecular forces can be reproduced in a small, human-made framework. The research was supported by the IAAR Research Support Program at Chiba University and by JSPS KAKENHI grant number 26K01496, and the authors declare no conflicts of interest. What began as an attempt to solve a stubborn stereochemical problem may end up reshaping how chemists think about controlling reactions altogether, one weak interaction at a time.

Subject of Research: Halogen-bond-assisted anti-selective Henry reaction using a chiral nickel catalyst for β-amino alcohol synthesis

Article Title: Innovative nickel catalyst unlocks hard-to-make β-amino alcohols

Article References: Innovative nickel catalyst unlocks hard-to-make β-amino alcohols. (n.d.). Original publication

Image Credits: AI Generated

DOI: Not provided

Keywords: nickel catalyst, β-amino alcohols, Henry reaction, halogen bonding, hydrogen bonding, enantioselective synthesis, organocatalysis, stereochemistry, Angewandte Chemie, Chiba University, artificial metalloenzymes, pharmaceutical building blocks

The research team, led by Yogesh Bhaskar Singh Tanwer, Suman Sourabh, and Sabyasachi Bhunia of the Central University of Jharkhand, together with Sanchari Pal and Debjit Das of Triveni Devi Bhalotia College, combined three simple ingredients in a single flask: a substituted salicylaldehyde, either 4-hydroxycoumarin or 1,3-dimethylbarbituric acid, and an electron-rich arene such as 1,3,5-trimethoxybenzene. Heating this mixture at 90 degrees Celsius in a mixture of lemon juice and ethanol produced the desired fused chromene products in yields ranging from 74 to 87 percent for the chromeno[4,3-b]chromene series and good to excellent yields for the chromeno[2,3-d]pyrimidine analogues. No metals, no exotic reagents, no chromatographic purification—just filtration and a wash with aqueous ethanol in most cases.

The appeal of multicomponent reactions lies in their efficiency. Rather than assembling a target molecule step by step, isolating and purifying intermediates at each stage, a multicomponent reaction stitches three or more building blocks together in one operation. This convergence saves time, energy, solvent, and manpower, which is why such reactions are prized in pharmaceutical and combinatorial chemistry. But traditional versions of these reactions often rely on volatile organic solvents and toxic or costly metal catalysts, undermining their green credentials. The Indian team’s approach sidesteps both problems by using a food-derived catalyst in a largely benign medium.

Lemon juice has been attracting growing attention as a biocatalyst in recent years. It is cheap, widely available, water-soluble, biodegradable, and non-toxic, and its natural acidity—derived primarily from citric acid—allows it to substitute for harmful metallic and non-metallic acid catalysts in a range of organic transformations. In the new study, the researchers found that lemon juice alone in water failed to deliver any product even after 24 hours of reflux, largely because the organic starting materials dissolve poorly in the aqueous juice. Adding ethanol as a co-solvent solved the solubility problem dramatically: with 2.0 milliliters of lemon juice and 1.5 milliliters of ethanol at 90 degrees Celsius, the model reaction between salicylaldehyde, 1,3,5-trimethoxybenzene, and 4-hydroxycoumarin delivered the product 4a in 89 percent yield.

With the optimized conditions in hand, the team explored how broadly the method could be applied. A variety of salicylaldehyde derivatives reacted smoothly with 1,3,5-trimethoxybenzene and 4-hydroxycoumarin, furnishing nine different chromeno[4,3-b]chromene products in 74 to 87 percent yields. Switching the coumarin component for 1,3-dimethylbarbituric acid redirected the chemistry toward chromeno[2,3-d]pyrimidines, seven derivatives of which were obtained in good to excellent yields. The researchers also demonstrated that dibenzylaniline, another strongly electron-rich arene, could serve as the arene component, giving the corresponding products in good yields, including a chromeno[2,3-d]pyrimidine in 78 percent yield.

The substrate scope does have a clear boundary. The reaction tolerates a range of substituents on the salicylaldehyde ring, but it works only with strongly electron-rich arenes. Weaker candidates such as mesitylene, dimethoxybenzene, and methoxynaphthalene showed little to no activity, a limitation that reflects the electrophilic character of the key intermediate in the reaction pathway. Even so, the products obtained represent a class of compounds that had not previously been accessible through a general protocol using direct arene functionalization at the 7 and 5 positions, making the method a genuine addition to the synthetic toolbox.

To understand how the reaction actually works, the team ran a series of control experiments. When salicylaldehyde and 1,3,5-trimethoxybenzene were heated together without the coumarin component, no adduct formed, ruling out a direct coupling pathway. When salicylaldehyde and 4-hydroxycoumarin were combined under the optimized conditions, a condensed product—labeled intermediate B—formed in 66 percent yield within six hours. The researchers isolated this intermediate, confirmed its structure by nuclear magnetic resonance spectroscopy, and then showed that reacting it with 1,3,5-trimethoxybenzene gave the final chromeno[4,3-b]chromene in 91 percent yield. This established that the three-component reaction proceeds through intermediate B rather than through a different sequence.

Based on these observations, the authors proposed a plausible mechanism. The acidity of the lemon juice first promotes a Knoevenagel condensation between the salicylaldehyde and the 4-hydroxycoumarin, generating the electron-poor Michael acceptor B. The electron-rich arene then adds to this acceptor in a Michael-type addition, producing an intermediate containing a tertiary carbon center. Finally, an acid-driven intramolecular ring closure followed by dehydration delivers the fused chromene product. In other words, the citric acid in the juice orchestrates every key step of the cascade, from initial condensation to final cyclization, without any metal assistance.

Practical considerations further strengthen the case for the method. The structures of two representative products were unambiguously confirmed by single-crystal X-ray crystallographic analysis, and all compounds were characterized by proton and carbon NMR spectroscopy, high-resolution mass spectrometry, and elemental analysis. Crucially, the team demonstrated that the reaction can be scaled up: a 10-millimole-scale run of the model compound proceeded with effectiveness and yields comparable to the small-scale experiments, suggesting genuine potential for commercial and industrial application. Because nearly all products precipitate from the reaction mixture, purification requires only filtration and washing, eliminating extraction steps, column chromatography, and the large volumes of harmful organic solvents they consume.

The significance of the work extends beyond the specific molecules made. Chromene derivatives are distributed widely in natural products, drugs, and edible plants, and their fused hybrids with coumarin or barbituric acid units display a striking range of pharmacological activities, including antitumor, anti-inflammatory, cytotoxic, antioxidant, antithrombotic, and antiplatelet effects, along with useful photophysical properties. A hybrid framework combining chromene with other bioactive analogues may incorporate the characteristics of both and enhance biological activity, which is precisely why synthetic chemists keep seeking better ways to build them. By replacing toxic metals and hazardous solvents with a kitchen staple, the Indian team has shown that the principles of green chemistry—waste prevention, safer solvents, catalysis, and energy efficiency—can be honored without sacrificing yield, scope, or scalability. The study was funded by the Science and Engineering Research Board and the University Grants Commission of India, and it stands as a vivid reminder that sometimes the most sustainable catalyst is sitting in the refrigerator.

Subject of Research: Lemon juice-mediated green synthesis of chromeno[4,3-b]chromene and chromeno[2,3-d]pyrimidine derivatives via one-pot three-component reactions

Article Title: Lemon juice mediated environmentally benign synthesis of functionalized chromeno[4,3-b]chromene/chromeno[2,3‐d]pyrimidine derivatives via one-pot three component reaction

Article References: Lemon juice mediated environmentally benign synthesis of functionalized chromeno[4,3-b]chromene/chromeno[2,3‐d]pyrimidine derivatives via one-pot three component reaction. (n.d.). https://doi.org/10.1007/s44509-026-00001-7

Image Credits: AI Generated

DOI: 10.1007/s44509-026-00001-7

Keywords: lemon juice, green chemistry, multicomponent reaction, chromene, chromenopyrimidine, organocatalysis, salicylaldehyde, 4-hydroxycoumarin, barbituric acid, Knoevenagel condensation, sustainable synthesis, metal-free catalysis

A team of chemists at Seoul National University led by Seung Youn Hong has now demonstrated a conceptually different route to the same goal, one that does not require bending a sulfur atom at all. Writing in Nature Catalysis, Woojin Lee, Jason Kim and colleagues describe a spirocyclic organosulfur scaffold in which four sulfur atoms are anchored to a single carbon centre, a geometric arrangement that forces the sulfur p orbitals into direct spatial overlap with one another. The result is a highest-occupied molecular orbital that is no longer localized on a single atom but spread across four sulfur centres simultaneously, and whose energy is substantially elevated compared with ordinary sulfides. In effect, the molecule manufactures its own reactivity not by distorting a single atom but by making several atoms share a common electronic frontier.

The underlying phenomenon, known as through-space orbital interaction, has been familiar to physical organic chemists for decades under the name spiroconjugation, and it has been exploited in optoelectronic materials, where spiro-linked frameworks tune the electronic properties of organic semiconductors. What the Seoul team has done is to transport this concept from materials science into catalysis. In their spirocyclic design, the rigid carbon framework holds the four sulfur atoms in a fixed three-dimensional relationship, ensuring that their lone-pair orbitals approach each other closely enough to mix. Computational analyses and sulfur K-edge X-ray absorption near-edge structure measurements, performed in collaboration with Jongwoo Lim’s group, confirmed that the highest-occupied molecular orbital is a genuine four-centred orbital with markedly raised energy, a signature that prototypical acyclic sulfides do not display.

Elevated orbital energy translates directly into chemical power. The highest-occupied molecular orbital governs a molecule’s nucleophilicity, its willingness to donate electron density into an incoming electrophile. A four-atom orbital spread across sulfur centres means that the sulfide form of the catalyst is an unusually potent nucleophile, far more electron-rich than a conventional thioether of comparable structure. The researchers showed that this enhanced nucleophilicity allows the spirocyclic sulfide to attack N-halosuccinimides, common halogen-transfer reagents, with pronounced ease, forming a sulfonium intermediate that carries an activated halogen ready for delivery to an arene substrate.

What makes the system a true catalyst rather than a stoichiometric reagent is the reversibility of this chemistry. Once the sulfonium species transfers its halogen to an aromatic ring, the catalyst is restored to its sulfide state and can re-enter the cycle. Mechanistic studies, including kinetic analyses designed to establish reaction orders, revealed a striking form of multi-atom cooperativity: the same four-centred orbital architecture that makes the sulfide state hyper-nucleophilic also endows the corresponding sulfonium state with an unusual capacity for halogen transfer. Both halves of the catalytic cycle, reduction and oxidation in a formal sense, are amplified by the shared orbital, which is precisely the kind of dual behaviour that geometrically constrained phosphorus catalysts achieve through distortion of a single centre.

The flagship application demonstrated by the team is electrophilic aromatic halogenation, one of the oldest and most industrially important reactions in organic chemistry. Aryl chlorides and bromides are ubiquitous in pharmaceuticals and agrochemicals; the chlorine atom alone appears in a large fraction of blockbuster drugs, where it modulates potency, metabolic stability and membrane permeability. Yet installing halogens onto complex, electron-poor or sterically congested arenes remains difficult, and existing organocatalytic halogenation methods each carry limitations in substrate scope or reactivity. The spirocyclic organosulfur catalyst proved capable of halogenating arenes that are otherwise hard to functionalize, exhibiting a level of activity that clearly distinguishes it from prototypical organosulfur compounds such as simple sulfides and even from previously reported specialized halogenation catalysts.

Of particular interest to the pharmaceutical community is the catalyst’s performance in late-stage functionalization. The researchers subjected drug-like molecules, scaffolds decorated with multiple sensitive functional groups, to the halogenation conditions and found that the spirocyclic catalyst could install halogen atoms selectively onto aromatic positions without disturbing the rest of the molecule. This kind of chemoselective, late-stage diversification is a prized capability in medicinal chemistry, where a single advanced intermediate may serve as the branching point for dozens of analogues in a structure-activity relationship study. A metal-free, organocatalytic platform that tolerates complex molecular architecture expands the synthetic toolkit available for such campaigns and avoids the toxicity and environmental concerns associated with many metal-based halogenation catalysts.

The study also carries conceptual weight for the broader field of main-group chemistry. Over the past fifteen years, chemists such as those working on geometrically constrained phosphorus(III) compounds and low-valent bismuth platforms have shown that main-group elements can mimic transition metals in catalysis, performing oxidative addition, redox cycling and bond activation once thought to be the exclusive province of the d-block. That programme, however, has been built almost entirely on the geometric-distortion principle, which is inherently element-specific. By showing that through-space orbital interactions can achieve an analogous electronic effect in a divalent chalcogen, the Seoul team has added a second, orthogonal design axis. The strategy is in principle transferable to other divalent elements and to other spirocyclic architectures, suggesting a generalizable route to multicentred main-group catalysts that does not depend on forcing unusual bond angles.

The experimental evidence underpinning the claims is unusually thorough for a conceptual advance. Crystallographic data for three representative spirocyclic compounds were deposited with the Cambridge Crystallographic Data Centre, establishing the solid-state structures and the spatial relationships between the sulfur atoms. Sulfur K-edge XANES spectroscopy, supported by simulations, probed the electronic structure of the sulfur centres in both the sulfide and sulfonium states, while quantum-chemical calculations mapped the composition and energy of the four-centred highest-occupied molecular orbital. Energy decomposition analyses traced the halogen-transfer step to the cooperative involvement of multiple sulfur atoms, providing a mechanistic rationale for why the multicentred catalyst outperforms its single-centred counterparts.

For a reaction as old as aromatic halogenation, the arrival of a genuinely new catalytic principle is noteworthy in itself. But the deeper significance of the work may lie in the demonstration that molecular orbitals can be engineered through architecture rather than distortion, that the spatial arrangement of identical atoms around a shared framework is itself a designable variable in catalyst development. If the spirocyclic strategy generalizes as the authors suggest, chemists may soon be building multicentred main-group catalysts for a wide range of transformations, from redox chemistry to bond activation, by simply deciding which atoms to bring within orbital reach of one another. The periodic table, it appears, still has unexploited modes of cooperation waiting to be switched on.

Subject of Research: Through-space orbital interactions in a spirocyclic tetrathiide scaffold that generate a four-centred high-energy HOMO for multicentred organosulfur catalysis

Article Title: Harnessing through-space orbital interactions for multicentred organosulfur catalysis

Article References: Harnessing through-space orbital interactions for multicentred organosulfur catalysis. (n.d.). https://doi.org/10.1038/s41929-026-01602-y

Image Credits: AI Generated

DOI: 10.1038/s41929-026-01602-y

Keywords: organosulfur catalysis, through-space orbital interactions, spiroconjugation, frontier molecular orbitals, main-group chemistry, electrophilic aromatic halogenation, multi-atom cooperativity, late-stage functionalization, sulfonium intermediates, organocatalysis, divalent chalcogens, Nature Catalysis

The significance of the result lies in the changing philosophy of drug design. For decades, approved medicines leaned heavily on flat, aromatic ring systems that were easy to synthesize but often suffered from poor solubility, metabolic liabilities and crowded intellectual property space. The influential concept of escape from flatland, articulated by Frank Lovering and colleagues in 2009, linked greater molecular saturation, quantified by the fraction of sp3 carbons, with improved clinical success rates. Since then, the fraction of sp3 character has become a recognized parameter of drug-likeness, and chemists have scrambled to invent efficient routes to saturated, three-dimensionally rich frameworks that can stand in for the aromatic and heteroaromatic rings of legacy drugs.

Piperidine is perhaps the single most important saturated ring in medicinal chemistry, appearing in a strikingly large share of FDA-approved pharmaceuticals, from analgesics to antipsychotics. But its ubiquity is precisely the problem: when a piperidine appears in a candidate drug, it offers limited novelty, and its geometry is a simple chair. Bioisosteres, fragments that mimic the size, shape and electronics of an established motif while changing its underlying scaffold, offer a route to analogues with altered physicochemical properties, modified metabolic profiles and defensible patent positions. Spirocyclic azetidines such as 2-azaspiro[3.3]heptane fuse a four-membered nitrogen-containing ring directly onto a cyclobutane at a single shared atom, producing a rigid, globular structure that projects substituents in three dimensions in ways piperidine cannot.

Until now, that promise has outrun practical access. Chemists led by Pavel Mykhailiuk and others had highlighted 1- and 2-azaspiro[3.3]heptanes as overlooked motifs for drug discovery and demonstrated their value as piperidine mimics, but the known routes were largely stoichiometric, lengthy and achiral, delivering racemic products or requiring resolution. No catalytic method for the asymmetric construction of 2-azaspiro[3.3]heptanes had been reported. Because most drug targets are chiral proteins, the two mirror-image forms of such a scaffold can behave very differently in the body, so a route that delivers a single enantiomer directly from simple precursors represents exactly the kind of enabling methodology that medicinal chemistry teams need.

The Chongqing team’s solution hinges on enantioselective reductive amination, a transformation in which a carbonyl compound and an amine combine to form an imine or iminium intermediate that is then reduced to a new carbon-nitrogen bond with catalyst-controlled chirality. Reductive amination is a mainstay of industrial chemistry, and catalytic versions using molecular hydrogen or metal hydrides are well developed; asymmetric variants have likewise been explored with transition metals and, pioneered by the groups of David MacMillan, Tsutomu Akiyama and Benjamin List, with chiral organic acids and hydride donors such as benzothiazolines. What the Dai group recognized was that this organocatalytic logic could be transplanted onto spirocyclic ketone substrates whose reduction would forge the stereogenic center at the heart of the 2-azaspiro[3.3]heptane framework in a single, convergent step.

In practice, a chiral phosphoric acid activates both the iminium formed from the spirocyclic ketone precursor and the hydride donor through simultaneous hydrogen bonding and ion pairing, creating a tightly organized chiral pocket in which hydride delivery to one face of the iminium is strongly preferred over delivery to the other. The result is a product enantiomer formed in high yield with excellent enantiomeric excess. Because the substrates are prepared from commercially available materials, the entire sequence offers a concise and scalable entry into scaffold variants that previously demanded multistep campaigns, and the reaction tolerates a broad range of amine partners and substitution patterns, as documented across the extensive substrate scope mapped in the study.

The authors did not stop at proving the reaction works. Mechanistic experiments and density functional theory calculations were used to map the possible reaction pathways and to rationalize the origin of the enantioselectivity, identifying the favored transition-state organization inside the catalyst pocket. Wavefunction-based analyses of the noncovalent interactions between catalyst and substrate provided a visual, quantified picture of the attractive forces that lock the iminium into the productive orientation. This combination of experiment and computation matters beyond the immediate reaction: it turns a useful empirical discovery into a transferable design principle that other groups can apply to related spirocyclic imines and to neighboring organocatalytic reductions.

The synthetic payoff is demonstrated in a series of onward transformations that convert the enantioenriched spirocycles into chiral building blocks suitable for the concise assembly of drug-like molecules. Most strikingly, the team applied the chemistry to an IRE1α inhibitor, a class of compounds that targets the unfolded protein response, a signaling pathway implicated in cancer survival. By swapping the piperidine motif of the inhibitor for the chiral 2-azaspiro[3.3]heptane bioisostere, the researchers obtained analogues exhibiting enhanced inhibitory activity together with improved absorption and metabolic properties. That a scaffold chosen for its three-dimensional shape also improves potency and pharmacokinetics in a real pharmacological context is precisely the outcome the bioisostere concept hopes for, and it is rarely demonstrated so directly.

The broader implications extend across the drug discovery pipeline. A robust catalytic route to chiral piperidine bioisosteres gives medicinal chemists a new, freely substitutable module for lead optimization: whenever a flat or metabolically fragile piperidine underperforms, this spirocycle can now be considered not just in principle but in practice, on scale, in either enantiomer. The work also strengthens the case for spirocyclic azetidines generally, a fragment class whose angular geometry and high fraction of sp3 character continue to attract attention in fragment-based screening and patent-focused scaffold hopping. As computational tools for predicting bioisosteric compatibility improve, methods such as this one supply the physical compounds those tools demand.

There are, of course, familiar caveats. The chemistry relies on organocatalytic transfer conditions whose substrate tolerance, while broad, will need to be stretched further for highly functionalized late-stage intermediates, and the cost and availability of chiral phosphoric acid catalysts on process scale will shape industrial uptake. Yet the trajectory of the field suggests these are engineering problems rather than conceptual barriers. What the Chongqing team has established is a first: the catalytic, asymmetric synthesis of 2-azaspiro[3.3]heptanes from simple starting materials, executed with the yields and selectivities that industrial adoption requires, validated computationally, and proven in a bona fide drug-discovery application. It is a vivid illustration of how modern organic synthesis, guided by the escape-from-flatland imperative, is quietly reshaping the chemical inventory from which the next generation of medicines will be built.

Beyond the headline result, the study offers a useful lesson in how stereochemical information can be installed at the very core of a ring system rather than at a peripheral substituent. In many asymmetric routes to saturated heterocycles, the stereocenter arises during bond formation at the scaffold’s edge, leaving the ring framework itself achiral. Here, the reductive amination step creates the stereogenic center at the spiro junction region, meaning the entire three-dimensional architecture inherits a defined handedness from the very operation that closes the molecule. That design choice is what allows the two enantiomers of the bioisostere to be accessed selectively, simply by switching the catalyst enantiomer.

The choice of a chiral phosphoric acid as catalyst also carries practical advantages worth noting. These organocatalysts are metal-free, operate under mild conditions, and avoid the residual heavy-metal concerns that can complicate the route from discovery chemistry toward good-manufacturing-practice production of clinical candidates. For pharmaceutical applications, where trace metal specifications are increasingly stringent, an organocatalytic entry to a chiral building block is an attractive feature in its own right, complementing the reaction’s use of commercially available starting materials.

The crystallographic work underpinning the study deserves mention as well. Definitive structural assignments for key products were secured through X-ray diffraction analyses, with the corresponding coordinates deposited in the Cambridge Structural Database, providing the community with verified three-dimensional reference structures of the scaffold. For a motif whose value depends precisely on its geometry, having experimentally determined structures available supports the computational modeling that medicinal chemists will inevitably perform when comparing the spirocycle against piperidine analogues.

Finally, the IRE1α application illustrates a point about how bioisosteric replacements should be evaluated. Rather than asserting similarity on purely geometric grounds, the authors measured what actually matters: target potency, absorption, and metabolic stability. The observation that the spirocyclic analogue outperformed its piperidine parent on these pharmacological endpoints provides empirical support for the escape-from-flatland hypothesis at the level of a specific drug target, evidence that will likely encourage other optimization campaigns to test saturated spirocyclic replacements earlier in the design cycle.

Subject of Research: Catalytic asymmetric synthesis of chiral 2-azaspiro[3.3]heptanes as piperidine bioisosteres for medicinal chemistry

Article Title: Enantioselective synthesis of chiral 2-azaspiro[3.3]heptanes and their application as piperidine bioisosteres

Article References: Qiu, Y.-K., Tang, Y.-P., Zhang, C.-G., Huang, Q., Li, J., Chen, L., Wang, Z., & Dai, L. (2026). Enantioselective synthesis of chiral 2-azaspiro[3.3]heptanes and their application as piperidine bioisosteres. Nature Synthesis. https://doi.org/10.1038/s44160-026-01147-9

Image Credits: AI Generated

DOI: 10.1038/s44160-026-01147-9

Keywords: 2-azaspiro[3.3]heptane, piperidine bioisostere, enantioselective synthesis, reductive amination, chiral phosphoric acid, asymmetric catalysis, organocatalysis, medicinal chemistry, spirocyclic azetidines, drug discovery, escape from flatland, IRE1α inhibitor